Researchers explore stem cell therapy for amyotrophic lateral sclerosis

06/19/2014 | Healio (free registration)

Mayo Clinic researchers will conduct an early-stage clinical trial of the use of stem cells to stop the progression of amyotrophic lateral sclerosis. Autologous modified fat-derived mesenchymal stem cells will be infused through a spinal tap to promote nerve cell survival.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC